1Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high- dose supplementation with vitamins C and E, Beta carotene, and Zinc for age-related macular degeneration and vision loss: AREDS report no. 8 [ J ]. Arch Ophthahnol, 2001, 119 (10) : 1439-1452. 被引量：1
2Nagpal M, Nagpal K, Sharma, et al. Transpupillary thermotherapy for treatment of choroidal neovascularization secondary to age-related macular degeneration in Indian eyes [ J ]. Indian J Ophthalmol, 2003, 51 ( 3 ) : 243 -250. 被引量：1
3Fujii GY, De JJ, Zarbin MA, et al. Unintentional transplantation of autologous retinal pigment epithelium during limited macular translocation [ J ]. Retina, 2001, 21 (4): 380-382. 被引量：1
4Toth CA, Freedman SF. Macular translocation with 360-degree peripheral retinectomy: Impact of techniquee and surgical experience on visual outcomes [J]. Retina, 2001,21 (4): 293-303. 被引量：1
5Joseph DP, Uemura A, Thomas MA. Subretinal surgery for juxafoveal choroidal neovascularization [J]. Retina, 2003,23(4) :463-468. 被引量：1
6Blinder KJ, Bradley S, Bressler NM, et al. Effect of lesion size, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1 [J]. Am J Ophthalmol, 2003, 136(3) : 407-418. 被引量：1
7Duker JS. A randomized clinical trial of a single dose of intravitreal trimcinolone acetonide for neovascular age- related macular degeneration [ J ]. Evidence-Based Eye Care, 2004, 5 (1): 16-18. 被引量：1
8Tolentino M J, Brucker AJ, Fosnot J, et al. Intrevitreal injection of vascular endothelial growth factor small interfering RNA inhibits growth and leakage in a nonhuman primate, laser-induced model of choroidal neovascularization [ J ]. Retina, 2004, 24(4) : 660. 被引量：1
9Ross RJ, Verma V, Rosenberg KI, et al. Genetic markers and biomarkers for age-related macular degeneration [ J ]. Expert Rev Ophthalmol, 2007, 2(3): 443-457. 被引量：1
1Brown AF, Jiang L, Fong DS, et al. For eye care among older adults with diabetes mellitus in fee-for-service and managed medicare. Arch Ophthalmol,2005, 123:669-675. 被引量：1
2The diabetic retinopathy study research group. A modification of the airlie house classification of diabetic retinopathy : DRS report 7. Invest Ophthalmol Vis Sci, 1981,21:210-216. 被引量：1
3Early treatment diabetic retinopathy study research group. Photocoagulation for diabetic macular edema. Arch Ophthalmol, 1985,103 : 1796-1806. 被引量：1
4Early photocoagulation for diabetic retinopathy. EDTRS report number 9: early treatment diabetic retinopathy study research group. Ophthalmology,1991,98:766-785. 被引量：1
5Early treatment diabetic retinopathy study research group. Pars plana vitreetomy in the early treatment diabetic retinopathy study: ETDRS report number 17. Ophthalmology, 1992,99 : 1351-1357. 被引量：1
6Diabetic retinopathy study research group. DRS group 8 photocoagulation treatment of proliferative diabetic retinopathy Ophthalmology, 1981,88 : 583 -600. 被引量：1
7British multicentre study group. Proliferative diabetic retinopothy: treatment with xenon-arc photocoagulation, interim report of multicentre randomised controlled trial. Br Med J, 1977,1 : 739- 741. 被引量：1
8British multicentre study group. Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings. Ophthalmology, 1978,85:82-106. 被引量：1
